News-Medical.Net on MSN
Medicaid Tries New Approach With Sickle Cell: Companies Get Paid Only If Costly Gene Therapies Work
Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting ...
At a Food and Drug Administration cell and gene therapy (CGT) roundtable last June, most speakers pushed for the agency to ...
A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
NHS Scotland has approved a one-time CRISPR gene therapy for severe sickle cell disease, offering durable reduction in ...
News-Medical.Net on MSN
ELRIG announces Drs Stephen Ward and Annarita Miccio as keynote speakers for cell and gene therapy 2026
ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, today announced the ...
GlobalData on MSN
Ocugen sets sights on Phase III after GA gene therapy win
GlobalData is the parent company of Clinical Trials Arena. "Ocugen sets sights on Phase III after GA gene therapy win" was ...
"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...
A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...
This virtual event is part of the Transforming Pediatric Healthcare series from U.S. News & World Report, developed with ...
Scientists from UC Davis Center for Surgical Bioengineering, the MIND Institute and UC Berkeley’s Murthy Lab are developing ...
Sarepta Therapeutics Inc. fell Monday after reporting its embattled gene therapy is expected to miss fourth-quarter sales ...
For those born with certain types of congenital deafness, the cochlear implant has been a positive and enabling technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results